Skip to main content

Peer Review reports

From: Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats

Original Submission
11 Aug 2022 Submitted Original manuscript
19 Nov 2022 Reviewed Reviewer Report
12 Dec 2022 Reviewed Reviewer Report
31 Jan 2023 Author responded Author comments - Jesper Mosolff Mathiesen
Resubmission - Version 2
31 Jan 2023 Submitted Manuscript version 2
1 Feb 2023 Author responded Author comments - Jesper Mosolff Mathiesen
Resubmission - Version 3
1 Feb 2023 Submitted Manuscript version 3
10 Feb 2023 Reviewed Reviewer Report
9 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
10 Mar 2023 Editorially accepted
21 Mar 2023 Article published 10.1186/s12876-023-02716-4

You can find further information about peer review here.

Back to article page